A diabetes patient with Health2Sync staff at a community event in Taiwan Health2Sync previously raised a $3 million Series A round in August 2016 and now this $6 million Series B will go towards expansions. Taiwanese company [UNK] is tackling the problem of diabetes in Japan , which accounts for 60 % of the world 's sufferers . It has developed a tracking service , combining a Bluetooth dongle and a mobile app , which allows users to monitor medication , diet and exercise , as well as offering analytics and feedback . Health2Sync said within three months , high - risk users experienced a 22 % drop in average blood sugar levels . The company , which recently closed a $ 6 m series B round , aims to expand beyond its main market in Japan into southeast Asia .
Taiwanese company [UNK] is tackling the problem of diabetes in Japan , which accounts for 60 % of the world 's sufferers . It has developed a tracking service , combining a Bluetooth dongle and a mobile app , which allows users to monitor medication , diet and exercise , as well as offering analytics and feedback . Health2Sync said within three months , high - risk users experienced a 22 % drop in average blood sugar levels . The company , which recently closed a $ 6 m series B round , aims to expand beyond its main market in Japan into southeast Asia .